Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 130
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

Phage-encoded small RNA hijacks host replication machinery to support the phage lytic cycle

Phage-encoded small RNA hijacks host replication machin...

 37

Partitioned polygenic scores show mechanistic heterogeneity in type 2 diabetes and hypertension comorbidity

Partitioned polygenic scores show mechanistic heterogen...

 36

Transcription and cohesin direct domain boundary spatial positioning and are linked to Friedreich’s ataxia

Transcription and cohesin direct domain boundary spatia...

 30